Skip to Main Content

Paper Details

Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial.
J Affect Disord
99
2019
Author NameAffiliation
Kate H BentleyDepression Clinical and Research Program, Massachusetts General Hospital, United States Harvard Medical School
Oluwaseun AkejuHarvard Medical School, Massachusetts General Hospital
Emery N BrownHarvard Medical School, Massachusetts General Hospital
Matthew K NockHarvard University
  • 1 - 4

Datasets